1 / 30

JPIAMR – Activity Update

JPIAMR – Activity Update. Laura Marin JPIAMR Head of Secretariat Swedish Research Council 02 April 2019. AMR is one of the t en threats to global health (WHO, 2019). AMR threatens a return to the pre-antibiotic era Annually in the EU:

rbooker
Télécharger la présentation

JPIAMR – Activity Update

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. JPIAMR –Activity Update Laura Marin JPIAMR Head of Secretariat Swedish Research Council 02 April 2019

  2. AMR is one of the ten threats to global health (WHO, 2019) • AMR threatens a return to the pre-antibiotic era • Annually in the EU: • 33,100 patients die from multidrug resistant bacteria annually (EARS-net) • extra health-care costs and productivity losses of at least €1500 million Euro per year • AMR projection (2050): 10 million people die each year worldwide (O’Neill report)

  3. Joint Programming Initiative on Antimicrobial Resistance Mission: To join forces across nations by leading the alignment, coordination, and support to Antimicrobial Resistance One Health collaborative research and global policy activities International collaborative platform that: • aligns national research funding • coordinates AMR research and funding on a global scale • supports collaborative action for filling knowledge gaps on AMR with a One Health perspective

  4. Uniting 27 countries to address AMR JPIAMR: A Global Organisation The European Commission (DG Research) is a full non voting member JPIAMR memberstates

  5. JPIAMR Governance Structure NATIONAL EXPERT PANELS & Mirror Groups SCIENTIFIC ADVISORY BOARD MANAGEMENT BOARD STEERING COMMITTEE SECRETARIAT Core Call Steering Group WG1 Evaluation WG3 Globalisation WG7 Industry relations WG2 Governance WG4 Policy Alignment WG5/6 Research Alignment

  6. JPIAMR Steering Committee Carlos Segovia, Spain (Chair) Jan-Ingvar Jönsson, Sweden (Vice-Chair) Antoine Andremont, France Joachim Klein, Germany Jonathan Pearce, UK Richard Gordon, South Africa

  7. JPIAMR Boards JPIAMR Working Groups

  8. JPIAMR CENTRAL SECRETARIAT at the Swedish Research Council (5FT) Head of Secretariat Laura Marin Senior Officers Calls supervision Laura Plant, Patriq Fagerstedt Maria Starborg VRI Coordinator Edith Brochu Analyst Evaluation Analysis ShawonLahiri Communication Officer Anders Bjers Administration Financial Administration Anna Sundin Mikaela Laine

  9. JPIAMR joint actions: international coordination platform

  10. Identifying the research needs:The JPIAMRStrategic Research and Innovation Agenda Interventions Therapeutics Diagnostics Environment Surveillance Transmission

  11. SRIA roadmaps of action 2019-2023

  12. JPIAMR mapped national research investment: an overview Majority of investment is in Therapeutics Investment in Environment is low 1 939 AMR projects National funding from 22 countries andthe European Commission and the Wellcome Trust Increase in national investments to AMR research Need more investment with One Health approach 1 794 M€ total investment 87% projects in antibiotic resistance Check the dashboard for more info www.jpiamr.eu/amr-research-funding-dashboard/ 6 JPIAMR priority areas Therapeutics, Diagnostics, Interventions, Transmission, Surveillance and Environment

  13. Global AMR research investments and projects

  14. Distribution of investmentat national level per priority area of research in 2014 and 2017 JPIAMR mapping • A better overall distribution of investment into the different priority areas categorised under the JPIAMR-SRA was observed in the 2017 JPIAMR mapping. • Majority of investment is in therapeutics; but pipeline still empty • A large gap for investments in environment at national levels still exists. • Need to continue more efforts with One Health approach

  15. JPIAMR workshops 2019

  16. Global AMR Research Funder • Total of 9 joint transnational research calls • Basic, pre-clinical and phase 1 clinical trials • To date 49 projects, 30 networks in AMR research have received over 65 M€ from JPIAMR

  17. JPIAMR funded 20 projects in Therapeutics research • 100 partners in 17 countries • 25M Euros invested JPIAMR supported research projects addressing pathogenscategorised under WHO Priority Pathogens List Distribution of JPIAMR funded projects on the basis of pathogens studied WHO priority pathogens Critical (Priority 1) TB High (Priority 2) Medium (Priority 3) Others

  18. JPIAMR funded 19 projects in Transmission research • 118 partners in 17 countries • 30M Euros invested

  19. JPIAMR Calls 2019-2023

  20. JPIAMR-Virtual Research Institute Connecting Bridging Partnerships, Collaborations, Forums, Workshops, Webinars Enabling Global Access, Mappings, Frameworks, Blueprints, Expertise, Knowledge Transfers Online Sharing Platforms, Libraries, Catalogues Knowledge Access Data Sharing JPIAMR-VRI Scientific Innovation • Building Evidence in all One Health domains of AMR Capacity Building Training, Virtual Education, Train the Trainers, Exchange Programs Awareness • Developing and Sharing research results, Promoting AMR in the Global Agenda

  21. JPIAMR-Virtual Research Institute Research Areas D C B A F E Connecting 1 Access 2 Data Sharing 3 Modules Scientific Innovation 4 Capacity Building 5 Awareness 6 Diagnostics Surveillance Therapeutics Transmission Interventions Environment VRI programmes

  22. Communications JPIAMR Communications • Implementation GDPR rules; databases management • New service for Newsletters. • Video: Interviews – workshops • Implementation of the new designs of logo, brand colours, templates, etc. • Development communication materials • Developed communications of the JPIAMR-VRI • Continuedcommunication of the JPIAMR Research FundingDashboard. • Preparinglaunch of the SRIA. • Traffic and engagement in digital channels is increasing. • Morerequests from media. Guidelines for media relations have been developed. • Planning update website

  23. Communications www.jpiamr.eu 8 867Uniquepageviews: The 9th Call on AMR Diagnostics and Surveillance. (ATH) 2 160 New users from USA. Now the toplocation. India is No. 2 with 1 341. 15 049 New users in Q1 2019. Up from 8 146 in Q1, 2019. 910Uniquepageviews: AMR Research FundingDashboard in Q1, 2019.

  24. Communications @jpiamr Twitter audience growth:Q1 2019 Twitter audiencegrowth: Q1 2018

  25. Communications @jpiamr Twitter Engagement: Q1 2019 Twitter Engagement: Q1 2018

  26. Communications International representation • European Antibiotic Awareness Day (EAAD), Brussels, 16 November 2018 • AMR call for Action (UN event), Accra (Ghana), 19 November 2018 • EU Parliament, Brussels, 29 January 2019 • ICARS meeting, Washington DC, February 2019 • EU AMR One Health Network meeting • 12th Berlin Conference on Life Sciences • UN Water Conference • Global Hub workshop • FEMS

  27. Many more activities running... And more to come in 2019!!! • Membership management • Expansion of the membership • Governancereinforcement – self-evaluation • Sustainability • International coordination • Peer review guidelines and new funding instruments • National Alignment, Policy Alignment • Industry relations • Research Infrastructures

  28. JPIAMR strategy • The Strategic Research Agenda (2014) • JPIAMR Implementation Plan 2015-2018 • JPIAMR Short Term Strategy 2018-2020 • JPIAMR Long Term Strategy 2020-2025 • NEXT: • JPIAMR Roadmaps of Actions 2019-2023 • Update Strategy • New Implementation Plan 2021-2023

  29. Thankyou www.jpiamr.eu twitter.com/JPIAMR facebook.com/JPIAMR

More Related